Dave Miller

2 weeks ago | themedicinemaker.com | Elizabeth Hickman |Dave Miller

The pharmaceutical development landscape is rapidly evolving with a growing focus on patient-centricity and precision medicine; treatments designed to target specific patient populations with greater efficacy and fewer side effects. This philosophical shift transitions our industry further away from traditional “one-size-fits-all” therapies, requiring more advanced formulation technologies and specialized expertise.

Dec 30, 2024 | machinedesign.com | Dave Miller

As 2025 approaches, manufacturers that embrace digital transformation—through advanced automation, IoT-enabled equipment and AI-driven insights—will be better equipped to enhance efficiency and remain competitive. Agility and interconnectivity will be key to successfully reimagining traditional processes. Here are five machining trends to watch in the year ahead. 1.

Nov 13, 2024 | outsourcedpharma.com | Dave Miller |Austin Px Pharmaceutics |Louis Garguilo

By Dave Miller, Ph.D., AustinPx Pharmaceutics and Manufacturing AI tools and machine learning have prompted the drug discovery’s most recent paradigm shift, enabling researchers to build compounds in-silico, without the constraints  of the physical realm. Docking experiments establishing the binding efficiency of these novel molecules to the target site are also conducted in-silico.

Oct 7, 2024 | outsourcedpharma.com | Dave Miller |Austin Px |Louis Garguilo

By Dave Miller, PhD, AustinPx Oral solid dose (OSD) formulation development must adhere to common considerations, such as project timelines, facilitating CDMO/client transparency and overcoming regulatory challenges. However, development’s difficulty often is compounded by numerous factors such as API supply constraints, challenging physiochemical properties, poor bioavailability, and/or constrained safe handling requirements, to name just a few.

Aug 23, 2024 | shorturl.at | Dave Miller

The lengthy offseason has finally come to an end. College football is back this week, albeit with a new look. A few power conferences became even more powerful and the Pac-12 is no longer, while keeping up with the transfer portal and NIL is a daily affair. But the games are what really matters, and they are finally back. Week 0 is lean, no doubt. But it’s ball. And it’s back.